Synlett 2003(4): 0527-0531
DOI: 10.1055/s-2003-37517
LETTER
© Georg Thieme Verlag Stuttgart · New York

Superacid Catalyzed Hydroxyalkylation of Aromatics with Ethyl Trifluoro­pyruvate: A New Synthetic Route to Mosher’s Acid Analogs

G. K. Surya Prakash*, Ping Yan, Béla Török, George A. Olah*
Loker Hydrocarbon Research Institute, Department of Chemistry, University of Southern California, University Park, Los Angeles, CA 90089-1661, USA.
Fax: +1(213)7406270; e-Mail: gprakash@usc.edu;
Further Information

Publication History

Received 20 January 2003
Publication Date:
26 February 2003 (online)

Abstract

A new superacid catalyzed Friedel-Crafts hydroxy­alkylation of aromatics with ethyl trifluoropyruvate is described. The trifluoromethanesulfonic acid or gallium(III) trifluoromethanesulfonate catalyzed reactions give α-hydroxy α-trifluoromethyl phenyl acetic acid ethyl ester and its derivatives (analogs of Mosher’s acid) in good yields for both highly activated hetero­aromatics and substituted benzenes.

    References

  • 1a Hiyama T. Organofluorine Compounds: Chemistry and Applications   Springer; Berlin, New York: 2000. 
  • 1b Banks RE. Smart BE. Tatlow JC. Organofluorine Chemistry: Principle and Commercial Applications   Plenum Press; New York: 1994. 
  • 1c Liebman JF. Greenberg A. Dolbier WR. Fluorine-Containing Molecules, Structure, Reactivity, Synthesis and Applications   VCH Publishers; Weinheim: 1988. 
  • 2a Filler R. Kobayashi Y. Yagupolskii LM. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications   Elsevier; Amsterdam: 1993. 
  • 2b Ojima I. McCarthy JR. Welch JT. Biomedical Frontiers of Fluorine Chemistry   ACS Symposium Series; Washington D. C.: 1996. 
  • 2c Kukhar VP. Soloshonok VA. Fluorine-Containing Amino Acids, Synthesis and Properties   Wiley; New York: 1995. 
  • 3a Lin P. Jiang J. Tetrahedron  2000,  56:  3635 
  • 3b Prakash GKS. Yudin KA. Chem. Rev.  1997,  97:  757 
  • 3c Prakash GKS. Mandal M. J. Fluorine Chem.  2001,  112:  123 ; and references cited therein
  • 4a Nelson DW. Owens J. Hiraldo D. J. Org. Chem.  2001,  66:  2572 
  • 4b Prakash GKS. Mandal M. Olah GA. Angew. Chem. Int. Ed.  2001,  40:  589 
  • 4c Bravo P. Crucianelli M. Vergani B. Zanda M. Tetrahedron Lett.  1998,  39:  7771 
  • 4d Xu Y. Dolbier WR. Tetrahedron Lett.  1998,  39:  9151 
  • 5a Dale JA. Dull DL. Mosher HS. J. Org. Chem.  1969,  34:  2543 
  • 5b Goldberg Y. Alper H. J. Org. Chem.  1992,  57:  3731 
  • 6a Streinz L. Svatos A. Vrkoc J. Meinwald J. J. Chem. Soc., Perkin Trans. 1  1994,  3509 
  • 6b Takahashi T. Fukushima A. Tanaka Y. Segawa M. Hori H. Takeuchi Y. Burchardt A. Haufe G. Chirality  2000,  12:  458 ; and references cited therein
  • 7a Dyachenko VI. Kolomiets AF. Fokin AV. J. Org. Chem. USSR (Engl. Transl.)  1992,  28:  1345 
  • 7b Dyachenko VI. Kolomiets AF. Fokin AV. Izv. Akad. Nauk, Ser. Khim.  1995,  3:  528 
  • 7c Golubev AS. Kolomiets AF. Fokin AV. Bull. Acad. Sci. USSR Div. Chem. Sci.(Engl.Transl.)  1989,  38:  2180 
  • 8a Zhuang W. Jorgensen KA. Chem. Commun.  2002,  1336 
  • 8b Zhuang W. Gathergood N. Hazell RG. Jørgensen KA. J. Org. Chem.  2001,  66:  1009 
  • 9 Gong Y. Kato K. J. Fluorine Chem.  2002,  1-5:  5735 
  • 10a Hazeldine RN. Kidd JM. J. Chem. Soc.  1954,  4228 
  • 10b Olah GA. Prakash GKS. Sommer J. Superacids   Wiley Interscience; New York: 1985. 
  • 10c Yato M. Ohwada T. Shudo K. J. Am. Chem. Soc.  1991,  113:  691 
  • 10d Sato Y. Ohwada T. Saito S. Shudo K. J. Am. Chem. Soc.  1995,  117:  3037 
  • 11 Boumizane K. Herzog-Cance MH. Jones DJ. Pascal JL. Potier J. Roziere J. Polyhedron  1991,  10:  2757 
  • 12 Olah GA. Angew. Chem., Int. Ed. Engl.  1993,  32:  767 
  • 13 Yamazaki T. Saito S. Ohwada T. Shudo K. Tetrahedron Lett.  1995,  36:  5749 
14

New compounds were characterized by NMR (1H, 19F, 13C) spectroscopy using Bruker AM-360 spectrometer. The spectra were recorded in CDCl3 using TMS and CCl3F as internal standards.
2,5-Di(α-carboethoxy-α-hydroxytrifluoroethyl)-pyrrole: 1H NMR (360 MHz, CDCl3): δ 1.39 (t, J = 7.3 Hz, 6 H), 4.34-4.53 (m, 6 H), 6.44 (s, 1 H), 6.45 (s, 1 H), 9.18 (br s). 19F NMR (338 MHz, CDCl3): δ -78.92 (s). 13C NMR (90 MHz, CDCl3): δ 167.7, 122.4 (q, J = 285.5 Hz), 123.0, 122.9, 75.0 (q, J = 32.3 Hz), 64.8, 13.8.
3,3,3-Trifluoro-2-hydroxy-2-(4-methylphenyl)-propion-ic acid ethyl ester: 1H NMR (250 MHz, CDCl3): δ 1.37 (t, J = 7.2 Hz, 3 H), 2.36 (s, 3 H), 4.30 (s, -OH), 4.31-4.52 (m, 2 H), 7.21 (d, J = 8.5 Hz, 2 H), 7.67 (d, 2 H). 19F NMR (470 MHz, CDCl3): δ -76.98. 13C NMR (125 MHz, CDCl3): δ 169.1, 139.6, 130.0, 129.1, 126.7, 123.1 (q, J = 285.5 Hz), 77.7 (q, J = 30.2 Hz), 64.3, 21.1, 13.9.
3,3,3-Trifluoro-2-hydroxy-2-(4-methoxyphenyl)-prop-ionic acid ethyl ester: 1H NMR (360 MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.3 Hz), 3.82 (s, 3 H), 4.29 (s, -OH), 4.33-4.52 (m, 2 H), 6.93 (d, 1 H, J = 9.0 Hz), 7.71 (d, 1 H). 19F NMR (338 MHz, CDCl3): δ -77.22 (s). 13C NMR (90 MHz CDCl3): δ 169.1, 160.5, 128.2, 124.8, 122.4 (q, J = 285.8 Hz), 113.8, 77.5 (q, J = 30.5 Hz), 64.3, 55.3, 13.9.
3,3,3-Trifluoro-2-hydroxy-2-(4- t -butylphenyl)-propionic acid ethyl ester:
1H NMR (360 MHz, CDCl3): δ 1.32 (s, 9 H), 1.38 (t, J = 7.0 Hz, 3 H), 4.30 (s, 1 H), 4.31-4.51 (m, 2 H), 7.42 (m, 2 H), 7.70 (d, 2 H, J = 8.3 Hz). 19F NMR (338 MHz, CDCl3): δ -76.93 (s). 13C NMR (90 MHz, CDCl3): δ 169.2, 152.7, 130.0, 126.6, 125.5, 123.2 (q, J = 285.6 Hz), 77.8 (q, J = 30.9 Hz), 64.4, 34.7, 31.3, 14.0.
3,3,3-Trifluoro-2-hydroxy-2-(4-fluorophenyl)-propionic acid ethyl ester:
1H NMR (360 MHz, CDCl3): δ 1.38 (t, J = 7.5 Hz, 3 H), 4.39 (s, 1 H), 4.34-4.53 (m, 2 H), 7.09 (m, 2 H), 7.80 (m, 2 H). 19F NMR (338 MHz, CDCl3): δ -77.20 (s), -112.66 (q, J = 9.1 Hz). 13C NMR (90 MHz, CDCl3): δ 168.75, 163.5 (d, J = 248.8 Hz), 128.9 (dd, J = 8.6 Hz, 2.7 Hz), 128.6 (d, J = 3.3 Hz), 122.9 (q, J = 285.7 Hz), 115.4 (d, J = 22.8 Hz), 77.4 (q, J = 30.5 Hz), 64.6, 13.8.
3,3,3-Trifluoro-2-hydroxy-2-(4-chlorophenyl)-propionic acid ethyl ester:
1H NMR (360 MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.5 Hz), 4.38 (s, 1 H), 4.30-4.52 (m, 2 H), 7.39 (d, 2 H, J = 8.6 Hz), 7.75 (d, 2 H). 19F NMR (338 MHz, CDCl3): δ -77.09 (s). 13C NMR (90 MHz, CDCl3): δ 168.7, 136.0, 131.4, 128.7, 128.5, 122.9 (q, J = 285.9 Hz), 77.5 (q, J = 30.6 Hz), 64.8, 13.9.
3,3,3-Trifluoro-2-hydroxy-2-(2,5-dimethylphenyl)-pro-pionic acid ethyl ester: 1H NMR (360 MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.3 Hz), 3.82 (s, 3 H), 4.29 (s, 1 H), 4.33-4.52 (m, 2 H), 6.93 (d, 1 H, J = 9.0 Hz), 7.71 (d, 1 H). 19F NMR (338 MHz, CDCl3): δ
-73.65 (s). 13C NMR (90 MHz, CDCl3): δ 169.9, 135.2, 134.5, 132.5, 131.3, 129.9, 128.0 (q, J = 3.8 Hz), 123.5 (q, J = 288.1 Hz), 79.6 (q, J = 28.8 Hz), 64.1, 21.2, 20.0, 13.8.
3,3,3-Trifluoro-2-hydroxy-2-(2,4,6-trimethylphenyl)-propionic acid ethyl ester:
1H NMR (360 MHz, CDCl3): δ 1.26 (t, J = 7.0 Hz, 3 H), 2.18 (s, 3 H), 2.35(s, 6 H), 3.23 (s, -OH), 4.17-4.33 (m, 2 H), 6.80 (s, 2 H). 19F NMR (338 MHz, CDCl3): δ -76.17 (s). 13C NMR (90 MHz, CDCl3): δ 168.5, 137.6, 137.5, 131.2, 126.8, 123.0 (q, J = 284.8 Hz), 80.3 (q, J = 30.2 Hz), 61.7, 21.6, 21.5, 19.4, 12.6.